The long-lasting epigenetic memory that withanolide F imposes on human cancer cells represents a novel paradigm and offers a unique opportunity for prolonged WNT-TCF pathway silencing following restricted treatment, leading to cancer stem cell exhaustion and tumor regression. This evidence concerns the gene HNF4A and cancer.